# Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients

> **NCT00754364** · PHASE2 · TERMINATED · sponsor: **Armando Santoro, MD** · enrollment: 108 (actual)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Pemetrexed/Carboplatin
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00754364
- **Lead sponsor:** Armando Santoro, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2014-05
- **Final completion:** 2015-12
- **Target enrollment:** 108 (ACTUAL)
- **Why stopped:** low enrollment rate
- **Last updated:** 2022-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754364, "Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00754364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*